- Translation- June 11, 2019 Subject: Notification the Acquisition of share of BS Myco Biotech Company Limited. (Additional Information Memorandum Concerning the Acquisition of Assets) To: Director and Manager
impairment of intangible assets - - 16.87 28.57 Loss from impairment finance costs and share of loss from associates 29.81 216.80 - - Doubtful Account 88.24 641.75 - - Loss from impairment of goodwill 51.20
decrease of Baht 56 million or a decrease of 14% compared to that of the previous year amounting to Baht 394 million. The decline was mainly due to the relocation of the production base of a former large
10.59% QoQ resulting from improving in production capability, efficiency and fuel management. Cost to revenue from sale of industrial equipment ratio in Q1-2020 decreased by 13.56% QoQ resulting from
of the acquisition of Modern Pharma Company Limited Board of Directors' opinion The meeting of shareholders should consider approving to expand the business to cover the production of human and animals
PUBLIC COMPANY LIMITED PTT EXPLORATION AND PRODUCTION PUBLIC COMPANY LIMITED PTT GLOBAL CHEMICAL PUBLIC COMPANY LIMITED PTT OIL AND RETAIL BUSINESS PUBLIC COMPANY LIMITED PTT PUBLIC COMPANY LIMITED PYLON
PUBLIC COMPANY LIMITED PTG ENERGY PUBLIC COMPANY LIMITED PTT EXPLORATION AND PRODUCTION PUBLIC COMPANY LIMITED PTT GLOBAL CHEMICAL PUBLIC COMPANY LIMITED PTT OIL AND RETAIL BUSINESS PUBLIC COMPANY LIMITED
shares of NINE, at the price of not lower than Baht 2.62 per share. This is the average price of the NINE’s ordinary shares received by the Company, as appeared in No. 6, Expected benefits to the Company
(Translation) — 1 — (Translation) No. 10000000/ 152 /61 20 June 2018 Subject: Resolutions passed by the Board of Directors Meeting regarding the share acquisition, the tender offer for the entire
investments in new machineries for replacements and a launch of the production automation under the scheme of Delta Smart Manufacturing. The company believes that it would be a key factor for the